Skip to content

Study for the regulation mechanism of acupuncture on brain-gut in patients with amnestic mild cognitive impairment

Clinical efficacy and regulatory mechanism of acupuncture for amnestic mild cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062084
Enrollment
Unknown
Registered
2022-07-21
Start date
2022-07-22
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amnestic mild cognitive impairment

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: The criteria claim that all patients: 1. Must meet the criteria: memory complaints and meets criteria by Jak/Bondi diagnostic criteria (17) in 2014; 2. Are from 50 to 80 years of age, right-handed, and Mandarin-speaking; 3. Have the course of the disease for at least three months; 4. Have a dementia score on the Clinical Dementia Scale (CDR) score = 0.5; 5. Have an ischemia score on Hachinski Ischemic Score (HIS) score = 4; 6. Have at least eight years of education, and could understand and complete the scale correctly; 7. Have signed informed consent; 8. Have no contraindications for MRI.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they met any of the following criteria: 1. In a treatment course that may interfere with cognitive function; 2. Other neurological disorders that may cause cognitive impairment (except for potential early Alzheimer's disease) include vascular dementia, Parkinson's disease, brain tumors, brain trauma leading to neurological impairment, and other brain structural abnormalities. Other systemic disorders that may bring about cognitive decline (anemia, metabolic encephalopathy, Hashimoto encephalopathy, etc.; 3. Brain MRI suggesting infection or other local lesions, multiple embolic infarctions, infarction in vital memory brain areas, or severe white matter lesions (Fazekas score = 3); 4. With tumor, psychiatric history (such as bipolar disorder, schizophrenia, severe anxiety (Hamilton Anxiety Scale (HAMA) = 29), and major depression (Hamilton Depression Scale (HAMD) = 24) according to DSM - V diagnostic criteria; 5. With bleeding tendency, hemorrhagic disease, or severe skin infection; 6. Severe drug dependence, smoking, drug, and alcohol abuse; 7. In a pregnant, lactation, or childbearing period; 8. In other clinical investigators within six months; 9. Regular use of probiotics, prebiotics, and antibiotics.

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Assessment Scale - Cognitive;MRI;Gut microbiota;

Secondary

MeasureTime frame
Auditory Verbal Learning Test;Montreal Cognitive Assessment - Basic;Functional Activities Questionnaire;Hamilton Anxiety Scale;Hamilton Depression Scale;Mild Behavioral Impairment Checklist;Pittsburgh Sleep Quality Index;

Countries

China

Contacts

Public ContactFanrong Liang
acuresearch@126.com+86 13608058216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026